GlassScriptPhysician profile
Heather N Gibbons-Doig
NPI 1164609335
$1,249.94
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.97 · 2020: $37.73 · 2021: $471 · 2022: $388 · 2023: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $374.61 | 2021-2023 | Wegovy |
| Abbvie INC. | $235.09 | 2021-2023 | |
| Therapeuticsmd, INC. | $104.92 | 2020-2022 | |
| Evofem Biosciences, INC. | $100.42 | 2021-2023 | Phexxi |
| Myovant Sciences INC. | $65.00 | 2021-2022 | |
| Agile Therapeutics, INC. | $55.65 | 2021-2022 | |
| Eisai INC. | $54.55 | 2019-2022 | |
| Exeltis, USA INC. | $44.21 | 2021-2023 | Slynd |
| Merck Sharp & Dohme LLC | $41.97 | 2021-2022 | |
| Allergan, INC. | $34.50 | 2019 | |
| Currax Pharmaceuticals LLC | $28.80 | 2021 | |
| Mayne Pharma Commercial LLC | $28.73 | 2022 | |
| Avion Pharmaceuticals | $27.38 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $15.30 | 2023 | Quviviq |
| Scynexis, INC. | $14.47 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $13.19 | 2022 | |
| Organon LLC | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Gibbons-Doig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.